Zyprexa News
Eli Lilly funds new Zyprexa study
- October 25, 2005
In response to thousands of patient complaints that Zyprexa causes diabetes-related weight gain, Eli Lilly and Co. has decided to fund a study about how to reduce the risk of Zyprexa weight gain. Eli Lilly agreed earlier this year to settle some 8,000 defective drug claims totaling $1 billion for those who have suffered significant weight gain as a result of taking Lilly's best-selling drug, Zyprexa. Thousands of consumers claim they were not informed that Zyprexa could cause weight gain and increase one's risk of developing diabetes.
The new Zyprexa study will be conducted by Menlo Park, CA-based pharmaceutical company, Corcept Therapeutics. In animal studies, this company has found their drug, Corlux showed promise in reducing the weight gain caused by Zyprexa. The company will now conduct human clinical trials to test the safety and effectiveness of using these two drugs in combination. This test will only involve healthy male participants. The two companies do not intend to make a combination drug.
Eli Lilly has agreed to fund the research and supply olanzapine (Zyprexa) for the study. In exchange, Corcept has agreed to share the research with Eli Lilly.
For more information on Zyprexa lawsuits, please contact us to confer with a Zyprexa attorney.
Homepage • Lawsuit • Alternatives • Heart Attack • Injuries • Warning • Withdrawal • Risk • Diabetes • Side Effects • Reports • Information • Zyprexa and Women • Resources • Safety • News • Lawsuit Evaluation • Site Map
Whether
or not Zyprexa and similar atypical antipsychotic drugs are linked to diabetes
is a question that will be answered in the Zyprexa lawsuits that have been
filed. Patients have reported deadly instances of Zyprexa side effects. There
are 288 reported cases of Zyprexa diabetes cases, including 23 deaths.
Zyprexa maker Eli Lilly has enjoyed large success with Zyprexa, with the drug
currently the world’s top selling schizophrenia medication. The Zyprexa
side effects causing Zyprexa lawsuits may begin slowing the company’s
current financial success. For more information on